Continuous Manufacturing in Biopharmaceuticals 2014

Key Topics

• Benefits of implementing continuous techniques compared to typical batch processes with Sanofi and GE Healthcare
• How to reduce cost, increase productivity and improve quality through continuous manufacturing
• Enable a fully integrated and validated process by streamlining the manufacturing strategy with case studies from Invite GmbH (Part of Bayer Group) and Genentech
• Innovative technologies in upstream and downstream development from ETH Zurith, IBET, Novasep and Astellas
• Key considerations for a successful scale up between a pilot study to GMP compliant environment with UCB and the Austrian Centre of Industrial Biotechnology
• Expectations on in-line and online monitoring and the analytical tools necessary to comply with regulatory expectations
• Benchmark your bioprocessing strategy against leading experts to ensure you are keeping up with industry demand